v3.25.4
REVENUE RECOGNITION (Tables)
12 Months Ended
Dec. 31, 2025
Disaggregation of Revenue [Line Items]  
Schedule of disaggregated revenue

Year Ended

(In millions)

December 31, 2025

December 31, 2024

December 31, 2023

Major revenue types

Admissions

$

2,652.8

$

2,560.5

$

2,690.5

Food and beverage

1,671.3

1,624.9

1,669.8

Other theatre:

Advertising

152.1

132.9

129.5

Other theatre

372.7

318.9

322.8

Other theatre

524.8

451.8

452.3

Total revenues

$

4,848.9

$

4,637.2

$

4,812.6

Year Ended

(In millions)

December 31, 2025

December 31, 2024

December 31, 2023

Timing of revenue recognition

Products and services transferred at a point in time

$

4,362.5

$

4,224.7

$

4,424.1

Products and services transferred over time (1)

486.4

412.5

388.5

Total revenues

$

4,848.9

$

4,637.2

$

4,812.6

(1)Amounts primarily include subscription and advertising revenues.

Schedule of receivables and deferred revenue income

(In millions)

December 31, 2025

December 31, 2024

Current assets

Receivables related to contracts with customers

$

95.1

$

86.0

Miscellaneous receivables

60.9

82.1

Receivables, net

$

156.0

$

168.1

(In millions)

December 31, 2025

December 31, 2024

Current liabilities

Deferred revenues related to contracts with customers

$

462.4

$

425.6

Miscellaneous deferred income

3.1

6.8

Deferred revenues and income

$

465.5

$

432.4

Schedule of transaction price allocated to the remaining performance obligations related to Exhibitor Service Agreements

(In millions)

Exhibitor Services Agreement

Year ended 2026

$

6.5

Year ended 2027

7.6

Year ended 2028

8.9

Year ended 2029

10.5

Year ended 2030

12.3

Years ended 2031 through February 2042

413.3

Total

$

459.1

Sales Channel, Directly to Consumer  
Disaggregation of Revenue [Line Items]  
Schedule of changes in contract liabilities

Deferred Revenues

Related to Contracts

(In millions)

with Customers

Balance December 31, 2023

$

415.3

Cash received in advance (1)

354.1

Customer loyalty rewards accumulated, net of expirations:

Admission revenues (2)

22.6

Food and beverage revenues (2)

39.5

Other theatre revenues (2)

(2.6)

Reclassification to revenue as the result of performance obligations satisfied:

Admission revenues (3)

(254.1)

Food and beverage revenues (3)

(75.8)

Other theatre revenues (4)

(73.2)

Foreign currency translation adjustment

(0.2)

Balance December 31, 2024

$

425.6

Cash received in advance (1)

393.8

Customer loyalty rewards accumulated, net of expirations:

Admission revenues (2)

19.7

Food and beverage revenues (2)

55.1

Reclassification to revenue as the result of performance obligations satisfied:

Admission revenues (3)

(256.9)

Food and beverage revenues (3)

(91.0)

Other theatre revenues (4)

(88.6)

Foreign currency translation adjustment

4.7

Balance December 31, 2025

$

462.4

(1)Includes movie tickets, food and beverage, gift cards, exchange tickets, subscription membership fees, and other loyalty membership fees.
(2)Amount of rewards accumulated, net of expirations, that are attributed to loyalty programs.
(3)Amount of revenue recognized from redemption of gift cards, exchange tickets, movie tickets, and rewards related to loyalty programs.
(4)Amounts relate to income from non-redeemed or partially redeemed gift cards, non-redeemed exchange tickets, subscription membership fees, and loyalty programs membership fees.
Sales Channel, Through Intermediary  
Disaggregation of Revenue [Line Items]  
Schedule of changes in contract liabilities

Exhibitor Services

(In millions)

Agreement (1)

Balance December 31, 2023

$

486.6

Other theatre revenue recognized, net of adjustments, as performance obligations are satisfied

(22.6)

Balance December 31, 2024

$

464.0

Contract modification consideration (1)

5.3

Other theatre revenue recognized as performance obligations are satisfied

(10.2)

Balance December 31, 2025

$

459.1

(1)The exhibitor services agreement contract liability relates to NCM common units that were previously received under the exhibitor services agreement dated February 13, 2007 and amended and restated as of December 13, 2013. On April 17, 2025, NCM entered into the Amended ESA with the Company. The term of the Amended ESA has been extended by five years through February 13, 2042. The Company treated the Amended ESA as a contract modification pursuant to ASC 606 – Revenue from Contracts with Customers. Accordingly, the Company has allocated the additional consideration received from the contract modification to the exhibitor services agreement contract liability and updated the discount rate used to account for the significant financing component to 16.12%. Prior to the contract modification, the weighted average discount rate used to account for the significant financing component was approximately 7.5%. The contract liability will be reclassified to other theatre revenue over the new term of the Amended ESA as the remaining performance obligations are satisfied.